HCW Biologics Faces Delisting Concerns
Ticker: HCWB · Form: 8-K · Filed: Mar 6, 2025 · CIK: 1828673
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
Related Tickers: HCWB
TL;DR
HCW Biologics might get delisted, check their latest filings.
AI Summary
HCW Biologics Inc. filed an 8-K on March 6, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The filing also includes financial statements and exhibits, with the earliest event reported on March 3, 2025. The company is incorporated in Delaware and headquartered in Miramar, Florida.
Why It Matters
This filing indicates potential issues with HCW Biologics' continued listing on an exchange, which could significantly impact its stock value and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's operations and stock value.
Key Numbers
- 001-40591 — Commission File Number (Identifies the company's SEC filing history.)
- 82-5024477 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- HCW Biologics Inc. (company) — Registrant
- March 03, 2025 (date) — Date of earliest event reported
- March 6, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of Incorporation
- Miramar, Florida (location) — Principal Executive Offices
FAQ
What specific listing rule or standard has HCW Biologics Inc. failed to satisfy?
The filing indicates a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard' but does not specify the exact rule in the provided text.
What is the date of the earliest event reported in this 8-K filing?
The earliest event reported is dated March 03, 2025.
Where are HCW Biologics Inc.'s principal executive offices located?
The principal executive offices are located at 2929 N. Commerce Parkway, Miramar, Florida, 33025.
What is the Commission File Number for HCW Biologics Inc.?
The Commission File Number for HCW Biologics Inc. is 001-40591.
What type of report is this filing, and when was it filed?
This is a Current Report on Form 8-K, filed on March 6, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 6, 2025 regarding HCW Biologics Inc. (HCWB).